HopeStage
Back to all studies
UnknownNCT04629352

Effect of Neuroplasticity Modulation in tDCS Treatment Response Among Schizophrenia Patients With Auditory Hallucination

Device studyAges 18–45India
The study in practice

Understand this study

Who could participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Listed locations
BengaluruSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: April 2, 2024
Recruitment status
Unknown
Enrollment listed in the registry
72
Sponsor
National Institute of Mental Health and Neuro Sciences, India
Sponsor type
Research institute
Study type
Device
Intervention type
Device
Locations
India
Age range
From 18 Years to 45 Years
Official registry ID
NCT04629352
Official title
Show the full official title

Examining Neuroplasticity Modulation as Mechanistic Basis of tDCS Treatment Effects on Auditory Verbal Hallucination in Schizophrenia

Recruitment & locations

Status unknown

Bengaluru

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Mental Health and Neuro Sciences, India, a research institute.

Who can participate?

This study is for people with schizophrenia. Listed age limits: 18 years to 45 years. Other eligibility criteria apply.

Want to explore more studies?

Explore studies